A multicenter, randomized, double-blind, placebo-controlled trial of high-dose intravenous immunoglobulin for oral corticosteroid-dependent asthma

Clinical Immunology

Volumn 91, Issue 2, 1999, Pages 126-133

  Kishiyama, J L ^a   Valacer, D ^b   Cunningham Rundles, C ^b   Sperber, K ^b   Richmond, G W ^c   Abramson, S ^d   Glovsky, M ^a   Stiehm, R ^a   Stocks, J ^e   Rosenberg, L ^a   Shames, R S ^a   Corn, B ^b   Shearer, W T ^d   Bacot, B ^d   Dimaio, M ^b   Tonetta, S ^a   Adelman, D C ^a  

^a Grifols SA   (United States)

^b Alpha Therapeut Corp Asthma S   (United States)

^c Alpha Therapeut Corp Asthma S   (United States)

^d Alpha Therapeut Corp Asthma S   (United States)

^e Alpha Therapeut Corp Asthma S   (United States)

Author keywords

Asthma; Intravenous immunoglobulin; Placebo controlled trial

Indexed keywords

CORTICOSTEROID; IMMUNOGLOBULIN; PLACEBO;

ADULT; AGED; ANTIINFLAMMATORY ACTIVITY; ARTICLE; ASTHMA; BRONCHUS HYPERREACTIVITY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORTICOSTEROID THERAPY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG EFFICACY; FEMALE; HEADACHE; HUMAN; INHALATIONAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; MENINGISM; MULTICENTER STUDY; NAUSEA; ORAL DRUG ADMINISTRATION; PHOTOPHOBIA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; VOMITING;

EID: 0032938814     PISSN: 15216616     EISSN: None     Source Type: Journal    
DOI: 10.1006/clim.1999.4714     Document Type: Article

References (38)

1. Schoenborn C. A., Marano M. Current estimates from the National Health Interview Survey: United States, 1988. Vital Health Stat. 10:1989;173.
2. National Asthma Expert Panel, In, (National Heart, Lung and Blood Institute, National Institutes of Health) Expert Panel Report 2: Guidelines for the Diagnosis and Management of Asthma. May 1997, 1997.
3. Wald J. A., Friedman B. F., Farr R. S. An improved protocol for the use of troleandomycin (TAO) in the treatment of steroid-requiring asthma. J. Allergy Clin. Immunol. 78:1986;36-43.
4. Mullarkey M. E., Blumenstein B. A., Andrade W. P., Bailey G. A., Olason I., Wetzel C. E. Methotrexate in the treatment of corticosteroid-dependent asthma. N. Engl. J. Med. 318:1988;603-607.
5. Bernstein D. L., Bernstein I. L., Bodenheimer S. S., Pietrusko R. G. An open study of Auranofin in the treatment of steroid-dependent asthma. J. Allergy Clin. Immunol. 81:1988;6-16.
6. Newburger J. W., Takahashi M., Burns J. C., Beiser A. S., Chung K. J., Duffy C. E., Glode M. P., Mason W. H., Reddy V., Sanders S. P. The treatment of Kawasaki syndrome with intravenous gamma globulin. N. Engl. J. Med. 315:1986;3417.
7. Newburger J. W., Takahashi M., Beiser A. S., Burns J. C., Bastian J., Chung K. J., Colan S. D., Duffy C. E., Fulton D. R., Glode M. P. A single infusion of gamma globulin as compared with four infusions in the treatment of acute Kawasaki syndrome. N. Engl. J. Med. 324:1991;1633-1639.
8. Imholz B., Imbach P., Baumgartner C., Berchtold W., Gaedicke G., Gugler E., Hirt A., Hitzig W., Mueller-Eckhardt C., Wagner H. P. IVIG for previously treated acute or for chronic ITP in childhood: A prospective multicenter study. Blut. 56:1988;63-38.
9. Van der Meche F. G., Schmitz P. The Dutch Guillain-Barre Study Group: A randomized trial comparing intravenous immune globulin and plasma exchange in Guillain-Barre syndrome. N. Engl. J. Med. 326:1992;1123.
10. Rossi, F. Sultan, Y. Kaztchkine, M. Spontaneous and therapeutic suppression of autoimmune response to factor VIII by anti-idiotypic antibodies, In, Clinical Use of Immunoglobulins, Academic Press, New York, 1986.
11. McGuire W. A., Yang H. H., Bruno E., Brandt J., Briddell R., Coates T. D., Hoffman R. Treatment of antibody-mediated pure red cell aplasia with high-dose intravenous gamma globulin. N. Engl. J. Med. 317:1987;1004-1008.
12. Roifman C. M., Schaffer F. M., Wachsmuth S. G., Murphy G., Gelfand E. W. Reversal of chronic polymyositis following intravenous immune serum globulin therapy. JAMA. 258:1987;513-515.
13. Dammacco F., Iodice G., Campobasso N. Treatment of adult patients with ITP with IVIG: Effects on circulating T cell subsets and PWM-induced antibody synthesis in vitro. Br. J. Hematol. 62:1986;125-135.
14. Silverman E. D., Laxer R. M., Greenwald M., Gelfand E., Shore A., Stein L. D., Roifman C. M. Intravenous gamma globulin therapy in systemic juvenile rheumatoid arthritis. Arthritis Rheum. 33:1990;1015-1022.
15. Imbach P., Jungi T. W. Possible mechanisms of IVIG treatment in childhood idiopathic thrombocytopenic purpura (ITP). Blut. 46:1983;117-124.
16. Leung D. Y. M., Burns J. G., Newburger J. W., Geha R. Reversal of lymphocyte activation in vivo in the Kawasaki syndrome by intravenous gamma globulin. J. Clin. Invest. 79:1987;468-472.
17. Amran D., Renz H., Bradley K., Lack G., Gelfand E. W. Suppression of cytokine dependent human T-cell proliferation by intravenous immunoglobulin. Clin. Immunol. Immunopathol. 73:1994;180-186.
18. Cook L., Howard J., Folds J. Immediate effects of IVIG administration on peripheral blood B and T cells and polymorphonuclear cells in patients with myasthenia gravis. J. Clin. Immunol. 8:1988;23-31.
19. Tsubakio T., Kurata Y., Katagiri S., Kanakura Y., Tamaki T., Kuyama J., Kanayama Y., Yonezawa T., Tarui S. Alteration of T cell subsets and immunoglobulin synthesis in vitro using high-dose gamma globulin therapy in patients with ITP. Clin. Exp. Immunol. 53:1983;697-702.
20. Kazatchkine M. D., Kaveri S. S., Nydegger U. E., Sultan Y. V region-mediated selection of autoreactive repertoires by intravenous immunoglobulin (I.v.Ig). Immunol. Rev. 139:1994;79-107.
21. Darville T., Tabor D., Simpson K., Jacobs R. F. Intravenous immunoglobulin modulates human mononuclear phagocyte tumor necrosis factor-α production in vitro. Pediatr. Res. 35:1994;397-403.
22. Andersson J. P., Andersson U. Human intravenous immunoglobulin modulates monokine production in vitro. Immunology. 71:1990;372-376.
23. Achiron A., Margalit R., Hershkovitz R., Markovits D., Reshef T., Melamed E., Cohen I. R., Lider O. Intravenous immunoglobulin treatment of experimental T-cell mediated autoimmune disease. J. Clin. Invest. 93:1994;600-605.
24. Arend W. P., Smith M. F., Janson R. W., Joslin F. G. IL-1 receptor antagonist and IL-1b production in human monocytes are regulated differently. J. Immunol. 147:1991;1530-1536.
25. Takei S., Arora Y. K., Walker S. M. Intravenous immunoglobulin contains specific antibodies inhibitory to activation of T cells by staphylococcal toxin superantigens. J. Clin. Invest. 91:1993;602-607.
26. Mazer B. D., Gelfand E. W. An open-label study of high-dose intravenous immunoglobulin in severe childhood asthma. J. Allergy Clin. Immunol. 87:1991;976-983.
27. Jakobsson T., Croner S., Kjellman N. I., Pettersson A., Vassella C., Bjorksten B. Slight steroid-sparing effect of intravenous immunoglobulin in children and adolescents with moderately severe bronchial asthma. Allergy. 49:1994;413-420.
28. Mazer B. D., Giclas P., Gelfand E. W. Immunomodulatory effects of intravenous immunoglobulin in severe steroid-dependent asthma. Clin. Immunol. Immunopathol. 53:1989;S156-S163.
29. Abernathy R., Strem E., Good R. Chronic asthma in childhood: Double blind controlled study of treatment with gammaglobulin. Pediatrics. 21:1958;980-993.
30. Page R., Friday G., Stillwagon P., Skoner D., Caliguiri L., Fireman P. Asthma and selective immunoglobulin subclass deficiency: Improvement of asthma after immunoglobulin replacement therapy. J. Pediatr. 112:1988;127-131.
31. Benson H., McCallie D. P. Angina pectoris and the placebo effect. N. Engl. J. Med. 300:1979;1424-1429.
32. Casteels Van Daele M., Wijndaele L., Hunnick K., Gillis P. Intravenous immunoglobulin and acute aseptic meningitis. N. Engl. J. Med. 323:1990;614-615.
33. Scribner C., Kapit R., Phillips E., Rickets N. Aseptic meningitis and intravenous immunoglobulin therapy. Ann Intern Med. 121:1994;305-306.
34. McCluskey D. R., Boyd N. A. Anaphylaxis with intravenous gammaglobulin. Lancet. 336:1990;874.
35. Rault R., Piraino B., Johnston J. R., Oral A. Pulmonary and renal toxicity of intravenous immune globulin therapy. Clin. Nephrol. 36:1991;83-86.
36. Brox A. G., Cournoyer D., Sternbach M., Spurll G. Hemolytic anemia following intravenous gammaglobulin administration. Am. J. Med. 93:1992;114-115.
37. Comenzo R. L., Malachowski M. E., Meissner H. C., Fulton D. R., Berkman E. M. Immune hemolysis disseminated intravascular coagulation and serum sickness after large dose of immune globulin given intravenously for Kawasaki disease. J. Pediatr. 120:1992;926-928.
38. Woodruff R. K., Grigg A. P., Firkin F. C., Smith I. L. Fatal thrombic events during treatment of autoimmune thrombocytopenia with intravenous immunoglobulin in elderly patients. Lancet. ii:1986;217-218.